FrancophonIA/ELRC3.0 huggingface dataset:
English: - If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not <take> <use> X” and “Warnings and precautions”) - If you are being treated with an ACE-inhibitor together with certain other medicines to treat your heart failure, which are known as mineralocorticoid receptors antagonists (MRA) (for example spironolactone, eplerenone).”
Finnish: - jos sinua hoidetaan ACE:n estäjällä samanaikaisesti tiettyjen muiden sydämen vajaatoiminnan hoitoon tarkoitettujen, mineralokortikoidireseptorin antagonisteina (MRA) tunnettujen lääkkeiden kanssa (esimerkiksi spinorolaktoni, eplerenoni)."
English: For candesartan-containing products with wording in section 4.1 stating that they can be used alone or in combination with other antihypertensive agents, the following cross-reference should be added: “(see sections 4.3, 4.4, 4.5 and 5.1)”.
Finnish: Kaikista kandesartaania sisältävistä valmisteista, joista kohdassa 4.1 mainitaan, että niitä voidaan käyttää yksin tai yhdessä muiden verenpainetta alentavien aineiden kanssa, kohtaan on lisättävä seuraava ristiviite: "(ks. kohdat 4.3, 4.4, 4.5 ja 5.1)".
English: Ref. EMEA/156698/2009
Finnish: Lontoo, 19.3.2009 Asiakirjaviite EMEA/291366/2009
English: Patients were either given Cylatron for up to five years or received no treatment.
Finnish: Potilaille joko annettiin Cylatronia viiden vuoden ajan tai he eivät saaneet mitään hoitoa.
English: The effects of Cylatron were first tested in experimental models before being studied in humans.
Finnish: Cylatronin vaikutuksia testattiin ensin kokeellisilla malleilla ennen ihmisillä tutkimista.
English: What is Cylatron?
Finnish: Mitä Cylatron on?
English: This decreases the rate at which the substance is removed from the body and allows the medicine to be given less often.
Finnish: Tämä hidastaa lääkeaineen poistumista elimistöstä, minkä ansiosta lääkettä voidaan antaa harvemmin.
English: The CHMP had concerns over side effects of Cylatron, particularly fatigue (tiredness) and depression.
Finnish: Lääkevalmistekomitea piti Cylatronin sivuvaikutuksia huolestuttavina, erityisesti uupumusta (väsymys) sekä masennusta.
English: Following the CHMP's opinion, it usually takes around two months for the European Commission to grant a licence.
Finnish: Kun lääkevalmistekomitea on antanut lausuntonsa, Euroopan komissio antaa myyntiluvan yleensä noin kahden kuukauden kuluttua.
English: In melanoma, interferon alfa-2b is thought to work by suppressing the growth and multiplication of cancerous cells, by causing these cells to die and by stimulating the immune system (the body's natural defences) to attack and kill the cancer cells.
Finnish: Melanooman hoidossa interferoni alfa-2b:n oletetaan toimivan estämällä syöpäsolujen kasvua ja monistumista tuhoamalla syöpäsoluja ja stimuloimalla immuunijärjestelmää (elimistön luonnollinen puolustusjärjestelmä) hyökkäämään syöpäsolujen kimppuun ja tuhoamaan ne.
English: On 11 March 2009, SP Europe officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Cylatron for the adjuvant treatment of stage III melanoma.
Finnish: SP Europe ilmoitti 11.3.2009 virallisesti lääkevalmistekomitealle (CHMP) haluavansa peruuttaa Cylatron-lääkevalmistetta koskevan myyntilupahakemuksensa.
English: Questions and answers on the withdrawal of the marketing application for Cylatron
Finnish: Kysymyksiä ja vastauksia myyntilupahakemuksen peruuttamisesta Lääkevalmiste: Cylatron
English: Cylatron was studied in one main study involving 1,256 adults with stage III melanoma.
Finnish: Cylatronia tutkittiin yhdessä päätutkimuksessa, johon osallistui 1 256 kolmannen asteen melanoomaa sairastavaa aikuista.
English: It was also concerned that, although the medicine showed some effects in delaying the return of the cancer, it had not been shown to be effective in increasing how long the patients survived.
Finnish: Lisäksi katsottiin, että vaikka lääkevalmisteella näytti olevan sairauden uusiutumista hidastava vaikutus, sen vaikutusta potilaiden elossapysymisajan pidentämiseen ei ollut osoitettu.
English: This withdrawal of application has no consequences on the use of PegIntron, ViraferonPeg and IntronA in their authorised indications, for which the balance of benefits and risks remains unchanged.
Finnish: Hakemuksen peruutus ei vaikuta PegIntronin, ViraferonPegin ja IntronA:n käyttöön niiden hyväksytyissä käyttöaiheissa, joissa riski-hyötysuhde pysyy ennallaan.
English: Based on the review of the data and the company's response to the CHMP list of questions at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Cylatron could not have been approved for adjuvant treatment of stage III melanoma.
Finnish: Saamiensa tietojen ja yhtiön kysymysluetteloon antamien vastausten tarkastelun perusteella lääkevalmistekomitea suhtautui varauksellisesti joihinkin seikkoihin peruuttamisajankohtana; sen alustava kanta oli, ettei Cylatronia voi hyväksyä lisälääkitykseksi III asteen melanooman hoitoon.
English: Cylatron was expected to be used in adults with stage III (advanced) melanoma as an add-on treatment after surgery, to prevent the disease from coming back.
Finnish: Cylatronia oli tarkoitus käyttää III asteen (edennyttä) melanoomaa sairastavien aikuispotilaiden hoidossa leikkauksen jälkeisenä lisälääkityksenä ehkäisemään sairauden uusiutumista.
English: When the study began, all of the patients had recently had surgery to remove lymph nodes containing melanoma cells.
Finnish: Kun tutkimus alkoi, kaikilta potilailta oli hiljattain poistettu melanoomasoluja sisältäviä imusolmukkeita.
English: Melanoma is a type of skin cancer affecting cells called melanocytes.
Finnish: Melanooma on ihosyövän tyyppi, joka vaikuttaa melanosyytti-nimisiin soluihin.
English: The company informed the CHMP that there are no consequences for patients currently included in clinical trials or compassionate programmes with Cylatron.
Finnish: Yhtiö on ilmoittanut lääkevalmistekomitealle, ettei peruuttamisesta ole mitään seurauksia potilaille, jotka osallistuvat Cylatronia koskeviin kliinisiin tutkimuksiin tai erityiskäyttöohjelmiin.
English: What are the consequences of the withdrawal for patients undergoing clinical trials or compassionate use programmes with Cylatron?
Finnish: Mitä seurauksia hakemuksen peruuttamisesta on Cylatronia koskeviin kliinisiin tutkimuksiin tai erityiskäyttöohjelmiin osallistuville potilaille?
English: What was Cylatron expected to be used for?
Finnish: Mihin Cylatronia oli tarkoitus käyttää?
English: It consists of a substance called interferon alfa-2b, which has been ‘pegylated' (coated with a chemical called polyethylene glycol).
Finnish: Se koostuu interferoni alfa2b -nimisestä aineesta, joka on ”pegyloitu” (pinnoitettu polyetyleeniglykoli-nimisellä kemikaalilla).
English: International non-proprietary name (INN): peginterferon alfa-2b
Finnish: Kansainvälinen yleisnimi (INN): peginterferoni alfa-2b
English: How is Cylatron expected to work?
Finnish: Miten Cylatronin odotettiin vaikuttavan?
English: What is happening with PegIntron and ViraferonPeg for the treatment of hepatitis C and with IntronA for the treatment of malignant melanoma?
Finnish: Mitä seurauksia hakemuksen peruuttamisesta on hepatiitti C:n hoidossa käytettäville PegIntron- ja ViraferonPeg-lääkevalmisteille ja pahanlaatuisen melanooman hoitoon käytettävälle IntronA-lääkevalmisteelle?
English: ‘Stage III' means that some cancer cells have spread to the lymph nodes (part of the lymphatic system that drains fluids from the body's tissues).
Finnish: Melanooman III aste tarkoittaa sitä, että syöpäsoluja on levinnyt imusolmukkeisiin (ne ovat osa elimistön imujärjestelmää, jonka tehtävänä on imeä nesteitä elimistön kudoksista).
English: Peginterferon alfa-2b has been authorised in the European Union (EU) since May 2000 as PegIntron and ViraferonPeg for the treatment hepatitis C. Unpegylated interferon alfa-2b has also been authorised in the EU since March 2000 as IntronA.
Finnish: Peginterferoni alfa-2b hyväksyttiin Euroopan unionissa (EU) toukokuussa 2000 kauppanimillä PegIntron ja ViraferonPeg hepatiitti C:n hoitoon.
English: Cylatron is a powder and solvent that is made up into a solution for injection.
Finnish: Cylatron sisältää injektiokuiva-ainetta ja liuottimen, joista valmistetaan liuos injektiota varten.
English: IntronA is authorised for the treatment of malignant melanoma after surgery, along with other diseases.
Finnish: IntronA on hyväksytty muiden sairauksien ohella pahanlaatuisen melanooman leikkauksen jälkeiseen hoitoon.
English: The active substance in Cylatron, peginterferon alfa-2b, belongs to the group ‘interferons'.
Finnish: Cylatronin vaikuttava aine, peginterferoni alfa-2b, kuuluu interferoneihin.
English: It contains the active substance peginterferon alfa-2b.
Finnish: Sen vaikuttava aine on peginterferoni alfa-2b.
English: The main measure of effectiveness was the how long the patients survived until the disease came back.
Finnish: Pääasiallinen tehon mittari oli ennen syövän uusiutumista kuluneen ajan pituus.
English: Cylatron was expected to be given to patients whose lymph nodes contained melanoma cells as visible under a microscope, but not when the cancer had caused the lymph nodes to become large enough to be felt through the skin.
Finnish: Cylatronia oli määrä antaa niille potilaille, joiden imusolmukkeissa on mikroskoopilla nähtäviä melanoomasoluja.
English: EU number
Finnish: EU-numero
English: Invented name Strength Pharmaceutical
Finnish: Vahvuus Lääkemuoto
English: Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, Marketing Authorisation Holders in the Member States
Finnish: Liite I Luettelo lääkevalmisteen nimistä, lääkemuodoista, vahvuuksista, antoreiteistä ja myyntiluvan haltijoista jäsenvaltioissa
English: Box 1711
Finnish: P.O. Box 1711
English: Modified-release capsule, hard
Finnish: Säädellysti vapauttava kapseli, kova
English: C. G. Papaloisou Ltd. Office address:
Finnish: C. G. Papaloisou Ltd.
English: Coated tablet
Finnish: Päällystetty tabletti
English: Gebouw Jupiter Herikerbergweg 100 Postbus 12021
Finnish: Gebouw Jupiter Herikerbergweg
English: Modified-release tablet
Finnish: Säädellysti vapauttava tabletti
English: Intramuscular use intravenous use
Finnish: Injektioneste, liuos Lihakseen Laskimoon
English: --1 Inactivated influenza A virus/human, strain A/Jena/VI5258/2009(H1N1)pdm09 ≥ 16 HU* *HU = haemagglutinating units
Finnish: --1 Inaktivoitua influenssa A-virusta/ihminen Kanta: A/Jena/VI5258/2009(H1N1)pdm09 ≥ 16 HU*
English: Annex A
Finnish: Liite A
English: Packaging Content
Finnish: Pakkaus Sisältö
English: Strength Pharmaceutical form
Finnish: Kauppanimi Vahvuus Lääkemuoto Kohdeeläinlaji(t)
English: EU (MA) Number Invented name
Finnish: EU-numero
English: Target species
Finnish: Antoreitti
English: Tipperary, Ireland
Finnish: Tipperary, Irlanti
English: Belgium Aktuapharma nv Ambachtenlaan 13E 3001 Leuven
Finnish: Aktuapharma nv Ambachtenlaan 13E 3001 Leuven Belgia
English: 26.200 28700 San Sebastián de los Reyes (Madrid) Spain
Finnish: 26.200 28700 San Sebastián de los Reyes (Madrid) Espanja
English: Hameenlinna Finland
Finnish: Hameenlinna Suomi
English: Al. Armii Ludowej 26 00-609 Warszawa Poland
Finnish: Al. Armii Ludowej 26 00-609 Warszawa Puola
English: 2 Ellinikou Str 16777,Elliniko, Athens Greece
Finnish: 2 Ellinikou Str 16777,Elliniko, Athens Kreikka
English: Norway ratiopharm Oy- Teva Group Menmber, Keilaranta 10 E, 02150 Espoo,
Finnish: Norja ratiopharm Oy- Teva Group Menmber, Keilaranta 10 E, 02150 Espoo,
English: Niepodleglosci 18 02-653 Warsaw Poland
Finnish: Niepodleglosci 18 02-653 Warsaw Puola
English: Mylan Sas 117, allée des Parcs 69800 Saint-Priest France
Finnish: Mylan Sas 117, allée des Parcs 69800 Saint-Priest Ranska
English: Benzstr.1 D-61352
Finnish: KG Benzstr.1 D-61352
English: Belgium Mylan BVBA/SPRL Terhulpsesteenweg 6A,
Finnish: Mylan BVBA/SPRL Terhulpsesteenweg 6A,
English: Belgium Teva Pharma Belgium Laarstraat 16
Finnish: Teva Pharma Belgium Laarstraat 16
English: C/ Ribera del Loira, 46
Finnish: C/ Ribera del Loira, 46 Edificio 2
English: 13500 HÄMEENLINNA Finland
Finnish: 13500 HÄMEENLINNA Suomi
English: Souffelweyersheim France
Finnish: Souffelweyersheim Ranska
English: Globegen Laboratories Limtied, 1406
Finnish: Iso-Britannia Globegen Laboratories Limtied, 1406
English: The Netherlands ratiopharm Nederland B.V.
Finnish: Alankomaat ratiopharm Nederland B.V.
English: Teva Sante 110, Esplanade du Général de Gaulle 92931 Paris La Défense Cedex France
Finnish: Teva Sante 110, Esplanade du Général de Gaulle 92931 Paris La Défense Cedex Ranska
English: Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the Member States
Finnish: Liite I Luettelo lääkevalmisteen nimistä, lääkemuodoista, vahvuuksista, antoreiteistä ja myyntiluvan haltijoista jäsenvaltioissa
English: Bayer Sante Familiale 33, Rue De L'industrie 74240 Gaillard France
Finnish: Bayer Sante Familiale 33, Rue De L'industrie 74240 Gaillard Ranska
English: B-1560 Hoeilaart Belgium
Finnish: B-1560 Hoeilaart Belgia
English: Barcelona Spain
Finnish: Barcelona Espanja
English: Sweden sanofi-aventis AB Box: 14142
Finnish: Ruotsi sanofi-aventis AB Box: 14142
English: Societe Cilfa Developpement 20, Rue Jean Daudin 75015 - Paris France
Finnish: Societe Cilfa Developpement 20, Rue Jean Daudin 75015 - Paris Ranska
English: 37, rue Saint-Romain 69379 Lyon Cedex 08 France
Finnish: 37, rue Saint-Romain 69379 Lyon Cedex 08 Ranska
English: Sweden Evolan Pharma AB Box: 120
Finnish: Evolan Pharma AB Box: 120
English: 22 quai Gallieni 92150 Suresnes France
Finnish: 22 quai Gallieni 92150 Suresnes Ranska
English: Belgium Sterop Laboratoires nv Avenue de Scheut 46
Finnish: Sterop Laboratoires nv Avenue de Scheut 46
English: 10237 Dolni Mecholupy Czech Republic
Finnish: 10237 Dolni Mecholupy Tšekin tasavalta
English: 69007 Lyon France
Finnish: 69007 Lyon Ranska
English: Chefaro Ireland Limited, First Floor, Block A, The Crescent Building, Northwood Office Park, Dublin 9, Ireland
Finnish: Chefaro Ireland Limited, First Floor, Block A, The Crescent Building, Northwood Office Park, Dublin 9, Irlanti
English: 032266 Bucureşti, Romania codeinum
Finnish: 032266 Bucureşti, Romania kodeiini
English: 92700 Colombes France
Finnish: 92700 Colombes Ranska
English: Sweden Meda AB Box 906
Finnish: Meda AB Box 906
English: 08228 Tarrasa (Barcelona) Spain
Finnish: 08228 Tarrasa (Barcelona) Espanja
English: Luxembourg Laboratoires SMB S.A. Rue de la Pastorale 26- 28 B 1080
Finnish: Luxemburg Laboratoires SMB S.A. Rue de la Pastorale 26- 28 B 1080
English: 28042 Madrid Spain
Finnish: 28042 Madrid Espanja
English: Luxembourg MEDA PHARMA 25 boulevard de l'amiral Bruix F-75016 Paris France
Finnish: Luxemburg MEDA PHARMA 25 boulevard de l'amiral Bruix F-75016 Paris Ranska
English: 69151 Décines Cedex France
Finnish: 69151 Décines Cedex Ranska
English: Mateo Inurria, 30 28036 Madrid Spain
Finnish: Mateo Inurria, 30 28036 Madrid Espanja
English: Luxembourg Mylan bvba/sprl Rozendal Businesspark Terhulpsesteenweg 6A B-1560 Hoeilaart Belgium
Finnish: Luxemburg Mylan bvba/sprl Rozendal Businesspark Terhulpsesteenweg 6A B-1560 Hoeilaart Belgia
English: Bayer Limited, The Atrium, Blackthorn Road, Dublin 18, Ireland
Finnish: Bayer Limited, The Atrium, Blackthorn Road, Dublin 18, Irlanti
English: Denmark Amgros I/S, Dampfærgevej 22, DK-2100 København Ø, Denmark
Finnish: Amgros I/S, Dampfærgevej 22, DK-2100 København Ø, Tanska
English: Germany Dr. R. Pfleger Chemische Fabrik GmbH
Finnish: Dr. R. Pfleger Chemische Fabrik GmbH
English: Sweden Recip AB Box: 906
Finnish: Recip AB Box: 906
English: ACTAVIS GROUP PTC EHF Reykjavikurvegur
Finnish: Iso-Britannia ACTAVIS GROUP PTC EHF Reykjavikurvegur
English: 92300 Levallois-Perret France
Finnish: 92300 Levallois-Perret Ranska
English: Ranbaxy Ireland Limited, Spafield, Cork Road, Cashel, Co.
Finnish: Iso-Britannia Ranbaxy Ireland Limited, Spafield, Cork Road, Cashel, Co.
English: FARMALIDER, S.A. Aragoneses, 15 28108 Madrid Spain
Finnish: FARMALIDER, S.A. Aragoneses, 15 28108 Madrid Espanja
English: Luxembourg GlaxoSmithKline Consumer Healthcare S.A. Site Apollo avenue Pascal 2-6 B1300 Wavre
Finnish: Luxemburg GlaxoSmithKline Consumer Healthcare S.A. Site Apollo avenue Pascal 2-6 B1300 Wavre
English: Luxembourg Meda Pharma GmbH&Co.
Finnish: Luxemburg Meda Pharma GmbH&Co.
English: Belgium Laboratoires SMB SA rue de la Pastorale 26
Finnish: Laboratoires SMB SA rue de la Pastorale 26
English: 92517 Boulogne Billancourt Cedex France
Finnish: 92517 Boulogne Billancourt Cedex Ranska
English: South Devon Healthcare NHS Foundation Trust, Torbay PMU, Long Road, Paignton, Devon TQ4 7TW
Finnish: Iso-Britannia South Devon Healthcare NHS Foundation Trust, Torbay PMU, Long Road, Paignton, Devon TQ4 7TW
English: Denmark Alternova A/S, Lodshusvej 11, DK4230 Skælskør, Denmark
Finnish: Alternova A/S, Lodshusvej 11, DK4230 Skælskør, Tanska
English: 6.1% w/v
Finnish: 6.1% w/v injektioneste lihakseen
English: 75014 Paris France
Finnish: 75014 Paris Ranska
English: Luxembourg Bristol-Myers Squibb Belgium S.A. Avenue de Finlande, 8 B-1420
Finnish: Luxemburg Bristol-Myers Squibb Belgium S.A. Avenue de Finlande, 8 B-1420
English: 2333 CR Leiden The Netherlands
Finnish: 2333 CR Leiden
English: Denmark Takeda Pharma A/S, Langebjerg 1, DK4000 Roskilde
Finnish: Takeda Pharma A/S, Langebjerg 1, DK4000 Roskilde Tanska
English: INTERNACIONAL, S.A. Gran Vía Carlos III, 94 08028 Barcelona Spain
Finnish: INTERNACIONAL, S.A. Gran Vía Carlos III, 94 08028 Barcelona Espanja
English: Seton Products Ltd., Tubiton House, Medlock Street, Oldham, OL1 3HS, United Kingdom
Finnish: Seton Products Ltd., Tubiton House, Medlock Street, Oldham, OL1 3HS, Iso-Britannia
English: Nitrianska 100, Hlohovec 920 27 Slovak Republic codeine
Finnish: Nitrianska 100, Hlohovec 920 27 Slovakia kodeiini
English: de Burgos, 91 28050 Madrid Spain
Finnish: de Burgos, 91 28050 Madrid Espanja
English: Pliva Ljubljana d.o.o., Pot k sejmišču 35, 1000 Ljubljana, Slovenia codeine, paracetamol, propyphenazone, caffeine
Finnish: Pliva Ljubljana d.o.o., Pot k sejmišču 35, 1000 Ljubljana, Slovenia kodeiini, parasetamoli, propyfenatsoni, kofeiini
English: Belgium Glaxosmithkline Consumer Healthcare sa
Finnish: Glaxosmithkline Consumer Healthcare sa
English: MAX REMEDIES LIMITED, Stoney Gate House, 2 Greenfield Road, Holmfirth, West Yorkshire, HD9 2JT, United Kingdom
Finnish: Iso-Britannia MAX REMEDIES LIMITED, Stoney Gate House, 2 Greenfield Road, Holmfirth, West Yorkshire, HD9 2JT, Iso-Britannia
English: 00101 Helsinki Finland
Finnish: 00101 Helsinki Suomi
English: 2610 Wilrijk
Finnish: 2610 Wilrijk Belgia
English: Germany Astellas Pharma GmbH Gearg-Brauchle-Ring
Finnish: Astellas Pharma GmbH Gearg-Brauchle-Ring
English: Quintanavides, 15 28050 Madrid Spain
Finnish: Quintanavides, 15 28050 Madrid Espanja
English: Clonmel Healthcare Ltd, Waterford Road, Conmel, Co. Tipperary Ireland
Finnish: Clonmel Healthcare Ltd, Waterford Road, Conmel, Co. Tipperary Irlanti
English: Pharmaceuticals Limited, No. 1
Finnish: Iso-Britannia Mercury Pharmaceuticals Limited, No. 1
English: Azur compositum SC Suppositorien suppository rectal use
Finnish: Azur compositum SC Suppositorien peräpuikko peräsuoleen
English: Str. Prahova, Nr. 6A, Sector 1, Bucureşti 012423, România paracetamol, fosfat de codeină hemihidrat, cafeină anhidră
Finnish: Str. Prahova, Nr. 6A, Sector 1, Bucureşti 012423, Romania parasetamoli, kodeiinifosfaattihemihy draatti, kofeiini vedetön
English: Laboratories Limited, Bampton Road, Harold Hill, Romford, Esses RM3 8UG,
Finnish: Iso-Britannia Macarthy's Laboratories Limited, Bampton Road, Harold Hill, Romford, Esses RM3 8UG,
English: Germany Temmler Werke GmbH Weihenstephaner Str.
Finnish: Temmler Werke GmbH Weihenstephaner Str.
English: LABORATORIES (HOLDINGS)LIMITED, Unit 2A Sefton Business Park, Aintree, Liverpool, L30 1RD, United Kingdom
Finnish: Iso-Britannia ZANZA LABORATORIES (HOLDINGS)LIMITED, Unit 2A Sefton Business Park, Aintree, Liverpool, L30 1RD, Iso-Britannia
English: Weifa AS, Hausmannsgate 6, P.O.Box 9113
Finnish: Weifa AS, Hausmannsgate 6, P.O.Box 9113 Grønland, NO-0133 Oslo,
English: 00351 Helsinki Finland
Finnish: 00351 Helsinki Suomi
English: Germany MEDA Manufacturing GmbH
Finnish: MEDA Manufacturing GmbH
English: 08013 Barcelona Spain
Finnish: 08013 Barcelona Espanja
English: Coventry Road, Yardley, Birmingham B25 8AE
Finnish: Yardley, Birmingham B25 8AE
English: GEDEON RICHTER ROMÂNIA SA Str. Cuza Vodă nr. 99105, Târgu-Mureş, Romania acid acetilsalicilic, paracetamol , fosfat de codeină hemihidrat , cafeină anhidră
Finnish: GEDEON RICHTER ROMÂNIA SA Str. Cuza Vodă nr. 99105, Târgu-Mureş, Romania asetyylisalisyylihappo, parasetamoli , kodeiinifosfaattihemihy draatti, kofeiini vedetön
English: Pedro IV, 499 08022 Barcelona Spain
Finnish: Pedro IV, 499 08022 Barcelona Espanja
English: 2012 HK Haarlem The Netherlands
Finnish: 2012 HK Haarlem
English: 75016 Paris France
Finnish: 75016 Paris Ranska
English: SW1V 2SA United Kingdom
Finnish: SW1V 2SA Iso-Britannia
English: Germany Stadapharm GmbH Stadastr.
Finnish: Stadapharm GmbH Stadastr.
English: Waymade Plc, Sovereign House, Miles Gray Road, Basildon, Essex SS14 3FR
Finnish: Iso-Britannia Waymade Plc, Sovereign House, Miles Gray Road, Basildon, Essex SS14
English: Luxembourg bene-Arzneimittel GmbH Herterichstraße 1-3 D-81479 München Germany
Finnish: Luxemburg bene-Arzneimittel GmbH Herterichstraße 1-3 D-81479 München Saksa
English: 3 Rue Joseph Monier 92500 Rueil Malmaison France paracetamol + codeine phosphate
Finnish: 3 Rue Joseph Monier 92500 Rueil Malmaison Ranska parasetamoli + kodeiinifosfaatti
English: 1170 Brussels Belgium
Finnish: 1170 Brussels Belgia
English: The Czech Republic
Finnish: Tšekin tasavalta
English: 5 mg/5ml 200 mg/5ml suspension
Finnish: 5 mg/5ml 200 mg/5ml suspensio
English: CONSILIENT HEALTH LIMITED, 5th floor, Beaux Lane, Mercer Street Lower, Dublin
Finnish: Iso-Britannia CONSILIENT HEALTH LIMITED, 5th floor, Beaux Lane, Mercer Street Lower, Dublin
English: 851 01 Bratislava Slovak Republic
Finnish: Einsteinova 24 851 01 Bratislava Slovakia
English: Germany ALIUD PHARMA GmbH Gottlieb-Daimler-Str.
Finnish: ALIUD PHARMA GmbH Gottlieb-Daimler-Str.
English: 08022 Barcelona Spain
Finnish: 08022 Barcelona Espanja
English: ENNOGEN PHARMA LIMITED, Unit G4, Riverside Industrial Estate, Riverside Way, Dartford, DA1 5BS United Kingdom
Finnish: Iso-Britannia ENNOGEN PHARMA LIMITED, Unit G4, Riverside Industrial Estate, Riverside Way, Dartford, DA1 5BS Iso-Britannia
English: Codeine (Chlorhydrate de) /acétylsalicylique (acide)/ paracétamol/paracétam ol granulé 96
Finnish: Kodeiini (klorhydraatti) /asetyylisalisyyli (happo)/ parasetamoli/parasetam oli granuloitu 96
English: 1080 Brussels Belgium
Finnish: 1080 Brussels Belgia
English: Germany Novartis Pharma GmbH
Finnish: Novartis Pharma GmbH
English: LABORATORIOS ERN, S.A. Pedro IV, 499 08022 Barcelona Spain
Finnish: LABORATORIOS ERN, S.A. Pedro IV, 499 08022 Barcelona Espanja
English: Via Lorenzini, 8 20139 Milano Italy paracetamol + codeine phosphate
Finnish: Via Lorenzini, 8 20139 Milano Italia parasetamoli + kodeiinifosfaatti
English: Brentford TW89GS United Kingdom paracetamol, codeine, caffeine
Finnish: Brentford TW89GS Iso-Britannia parasetamoli, kodeiini, kofeiini
English: Soluble Cupanol-Co Lemon Flavour effervescent tablet
Finnish: Soluble Cupanol-Co Lemon Flavour poretabletti
English: HEALTHCARE, Conway street,Hove, East sussex, BN3 3LW United Kingdom
Finnish: Iso-Britannia CUSTOM HEALTHCARE, Conway street,Hove, East sussex, BN3 3LW Iso-Britannia
English: GlaxoSmithKline Consumer Healthcare (Ireland) Limited, Stonemasons Way, Rathfarnham, Dublin 16, Ireland
Finnish: GlaxoSmithKline Consumer Healthcare (Ireland) Limited, Stonemasons Way, Rathfarnham, Dublin 16, Irlanti
English: Germany Pfizer Pharma GmbH Linkstr.
Finnish: Pfizer Pharma GmbH Linkstr.
English: Wockhardt UK Ltd., Ash Road North Wrexham, LL13 9 UF, United Kingdom
Finnish: Wockhardt UK Ltd., Ash Road North Wrexham, LL13 9 UF, Iso-Britannia